These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8392549)

  • 1. Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis.
    Brooks DP; Giardina G; Gellai M; Dondio G; Edwards RM; Petrone G; DePalma PD; Sbacchi M; Jugus M; Misiano P
    J Pharmacol Exp Ther; 1993 Jul; 266(1):164-71. PubMed ID: 8392549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.
    Wang YX; Clarke GD; Sbacchi M; Petrone G; Brooks DP
    J Pharmacol Exp Ther; 1994 Jul; 270(1):244-9. PubMed ID: 8035321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs.
    Brooks DP; Valente M; Petrone G; Depalma PD; Sbacchi M; Clarke GD
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1176-83. PubMed ID: 9067301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa-opioid receptors behind the blood-brain barrier are involved in the anti-hypertensive effects of systemically administered kappa-agonists in the conscious spontaneously hypertensive rat.
    Shen S; Ingenito AJ
    J Pharm Pharmacol; 1999 Nov; 51(11):1251-6. PubMed ID: 10632082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependent.
    Brooks DP; Edwards RM; Depalma PD; Fredrickson TA; Hieble JP; Gellai M
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1277-82. PubMed ID: 1684820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of selective kappa-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats.
    Zaratin P; Clarke GD
    Eur J Pharmacol; 1994 Oct; 264(2):151-6. PubMed ID: 7851477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. kappa-Opioid agonist inhibition of osmotically induced AVP release: preferential action at hypothalamic sites.
    Rossi NF; Brooks DP
    Am J Physiol; 1996 Feb; 270(2 Pt 1):E367-72. PubMed ID: 8779961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide.
    Zeynalov E; Nemoto M; Hurn PD; Koehler RC; Bhardwaj A
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):414-20. PubMed ID: 16049424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of fedotozine compared to other kappa agonists on diuresis in rats.
    Soulard CD; Guerif S; Payne A; Dahl SG
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1379-85. PubMed ID: 8968362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aquaretic agents].
    Jiménez W
    Nefrologia; 2002; 22 Suppl 5():52-5. PubMed ID: 12107918
    [No Abstract]   [Full Text] [Related]  

  • 13. Antidiuretic effects of a nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to rats.
    Nakamura S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Yamamura Y; Mori T; Tominaga M
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1005-11. PubMed ID: 11082435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
    Croci T; Landi M; Gully D; Maffrand JP; Le Fur G; Manara L
    Br J Pharmacol; 1997 Apr; 120(7):1312-8. PubMed ID: 9105707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
    Gottlieb HB; Varner KJ; Kenigs VA; Cabral AM; Kapusta DR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):678-85. PubMed ID: 15381735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin and angiotensin receptors of the medial septal area of the brain in the control of thirst and salt appetite induced by vasopressin in water-deprived and sodium-depleted rats.
    Maria Pavan de Arruda Camargo G; Antônio de Arruda Camargo L; Saad WA
    Pharmacol Biochem Behav; 2007 Oct; 87(4):393-9. PubMed ID: 17573101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa opiate agonist RU 51599 inhibits vasopressin gene expression and osmotically-induced vasopressin secretion in vitro.
    Rossi NF; Kim JK; Summers SN; Schrier RW
    Life Sci; 1997; 61(23):2271-82. PubMed ID: 9408050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antitussive activity of delta-opioid receptor stimulation in guinea pigs.
    Kotzer CJ; Hay DW; Dondio G; Giardina G; Petrillo P; Underwood DC
    J Pharmacol Exp Ther; 2000 Feb; 292(2):803-9. PubMed ID: 10640321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct.
    Rouch AJ; Kudo LH; Hébert C
    J Pharmacol Exp Ther; 1997 Apr; 281(1):62-9. PubMed ID: 9103481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
    Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M
    Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.